Application no. and date | 12785929.6 (espacenet) (Federated) (European Patent Register), 20120517 | Patent/reg. no. and date | DK/EP 2710033, 20210120 | Publication date | 20140326 | Priority no. and date | US 201161486960 P, 20110517 | EP pub. no. and date |
EP 2710033 20140326 | Effective date | | Applicant/owner | The Rockefeller University, 1230 York Avenue
New York, NY 10065, US, California Institute of Technology, 1200 East California Boulevard M/C 6-32 Pasadena CA 91125, US | Applicant ref. no. | P75773DK01 | Inventor | SCHEID, Johannes, 500 East 63rd Street, Apt. 5B
New York, NY 10065, US, NUSSENZWEIG, Michel, 15 East 91 Street, Apt. 8B
New York, NY 10128, US, BJORKMAN, Pamela, J., 5210 La Sierra Drive
La Cañada Flintridge, CA 91011, US, DISKIN, Ron, 204 S. Holliston, 12
Pasadena, CA 91101, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 39/21 (2006.01) , C07K 16/08 (2006.01) , C07K 16/10 (2006.01) | Title | HUMAN IMMUNDEFEKTVIRUS-NEUTRALISERENDE ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | US2012038400 | Int. publication no. | WO2012158948 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|